Source: Annual Congress 2004 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. N. Bogdan, M. Branaru, M. F. Draghici, P. Galbenu, M. A. Bogdan (Bucharest, Romania). The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat. Eur Respir J 2004; 24: Suppl. 48, 3463

Member's Comments

No comment yet.

Related content which might interest you: Reversibility of the monocrotaline pulmonary hypertension rat model Source: Eur Respir J 2013; 42: 553-556 Year: 2013 Effect of roflumilast on hypoxia- and monocrotaline-induced pulmonary hypertension in rats Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Bevacizumab administration in monocrotaline induced pulmonary arterial hypertension rat model Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 The effect of acetazolamide on pulmonary hypertension induced by chronic hypoxia in rats Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Roflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigs Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006 VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Pirfenidone protects against pulmonary hypertension in the Sugen5416/hypoxia rat model Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats Source: Eur Respir J 2005; 26: Suppl. 49, 291s Year: 2005 Is 7.5 mg/Kg of bleomycin safe in inducing pulmonary fibrosis in wistar rats? Source: Annual Congress 2007 - Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease Year: 2007 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Effects of prostacyclin analogous iloprost trometamol on bleomisin induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Effect of zamicastat, a dopamine beta-hydroxylase inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Effect of oral administration of echinochrome on lipopolysaccharide-induced lung injury in the immature Wistar rats Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 The effect of captoril on pulmonary fibrosis in rats and its possible mechanisms Source: Eur Respir J 2006; 28: Suppl. 50, 306s Year: 2006 Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Acute lung injury induced by the pyrrolizidine alkaloid monocrotaline in mice Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Source: Eur Respir J 2001; 17: 1228-1235 Year: 2001